Shenzhen JYMed Technology Co., Ltd. (hadda dambe loo yaqaan JYMed) waxaa la aasaasay 2009, ku takhasusay cilmi-baarista, horumarinta, wax soo saarka, iyo iibinta peptides iyo peptide la xiriira alaabta. Iyada oo leh hal xarun cilmi baaris iyo saddex saldhig oo wax soo saar oo waaweyn, JYMed waa mid ka mid ah soosaarayaasha ugu weyn ee API-yada kiimikaad lagu farsameeyey ee peptide ee Shiinaha. Kooxda R&D ee xudunta u ah shirkadu waxay ku faantaa in ka badan 20 sano oo waayo-aragnimo ah warshadaha peptide waxayna si guul leh uga gudubtay baaritaannada FDA laba jeer. Nidaamka warshadaynta peptide ee dhamaystiran oo hufan ee JYMed waxay siisaa macaamiisha adeegyo kala duwan oo buuxa, oo ay ku jiraan horumarinta iyo soosaarka peptides-daweynta, peptides-ka caafimaadka xoolaha, peptides antimicrobial, iyo peptides-ka qurxinta, iyo sidoo kale diiwaangelinta iyo taageerada sharciyeynta.

Hawlaha Ganacsiga ee ugu muhiimsan

1.Diiwaan galinta gudaha iyo dibada ee peptide APIs

2. peptides-ka caafimaadka xoolaha iyo kuwa la isku qurxiyo

3.Custom peptides iyo CRO, CMO, adeegyada OEM

4.PDC (peptide-radionuclide, peptide-small molecule, peptide-protein, peptide-RNA)

Marka lagu daro Tirzepatide, JYMed waxay soo gudbisay diiwaan gelinta FDA iyo CDE dhowr alaab oo API ah, oo ay ku jiraan daawooyinka fasalka GLP-1RA ee hadda caanka ah sida Semaglutide iyo Liraglutide. Macaamiisha mustaqbalka ee isticmaalaya alaabta JYMed waxay awood u yeelan doonaan inay si toos ah u tixraacaan lambarka diiwaangelinta CDE ama lambarka faylka DMF marka ay soo gudbinayaan codsiyada diiwaangelinta FDA ama CDE. Tani waxay si weyn u dhimi doontaa wakhtiga loo baahan yahay diyaarinta dukumentiyada codsiga, iyo sidoo kale wakhtiga qiimaynta iyo qiimaha dib u eegista alaabta.